Stocktoria
RESMED INC RMD
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-06-01
RESMED INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% |
| Operating margin | 32.7% | 28.2% | 26.8% | 28.0% | 28.3% |
| Net margin | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% |
| FCF margin | 32.3% | 27.8% | 13.6% | 6.0% | 19.8% |
| Return on assets | 17.1% | 14.9% | 13.3% | 15.3% | 10.0% |
| Return on equity | 23.5% | 21.0% | 21.7% | 23.2% | 16.4% |
| Debt / equity | 0.11× | 0.14× | 0.35× | 0.23× | 0.22× |
| Current ratio | 3.44 | 2.59 | 3.12 | 2.80 | 1.73 |
| Revenue growth | 9.8% | 10.9% | 18.0% | 11.9% | 8.1% |
Source: SEC EDGAR filings · CIK 0000943819 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.